Literature DB >> 15156211

Lack of association between long-term illness and infectious intestinal disease in New Zealand.

Rob Lake1, Michael Baker, Carolyn Nichol, Nick Garrett.   

Abstract

AIMS: To investigate whether the increase in notified cases of infectious intestinal disease in New Zealand from 1988 to 2001 has resulted in a concurrent increase in associated secondary illness cases.
METHODS: National surveillance system data were compared to hospital discharge data.
RESULTS: No statistically significant correlation between the number of cases of campylobacteriosis and Guillain-Barre syndrome (GBS) was found. There was no statistically significant correlation between the number of cases of campylobacteriosis, salmonellosis, shigellosis, and any of the categories of reactive arthritis; apart from two correlations with campylobacteriosis: with arthropathy associated with Reiter's disease and nonspecific urethritis (Pearson correlation R2=0.69; p<0.02) and unspecified infective arthritis (Pearson correlation R2=0.75; p<0.008). The later category is likely to include cases of both infective and non-infective aetiology.
CONCLUSION: In New Zealand, infectious intestinal diseases are not making a significant contribution to the burden of hospitalisation for reactive arthritis or GBS.

Entities:  

Mesh:

Year:  2004        PMID: 15156211

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  3 in total

1.  Is the major increase in notified campylobacteriosis in New Zealand real?

Authors:  M G Baker; E Sneyd; N A Wilson
Journal:  Epidemiol Infect       Date:  2006-06-06       Impact factor: 2.451

2.  Declining Guillain-Barré syndrome after campylobacteriosis control, New Zealand, 1988-2010.

Authors:  Michael G Baker; Amanda Kvalsvig; Jane Zhang; Rob Lake; Ann Sears; Nick Wilson
Journal:  Emerg Infect Dis       Date:  2012-02       Impact factor: 6.883

3.  Genomic diversity and adaptation of Salmonella enterica serovar Typhimurium from analysis of six genomes of different phage types.

Authors:  Stanley Pang; Sophie Octavia; Lu Feng; Bin Liu; Peter R Reeves; Ruiting Lan; Lei Wang
Journal:  BMC Genomics       Date:  2013-10-20       Impact factor: 3.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.